Identifications of good and bad structural fragments of hydrazone/2,5-disubstituted-1,3,4-oxadiazole hybrids with correlation intensity index and consensus modelling using Monte Carlo based QSAR studies, their molecular docking and ADME analysis

References

• J. Wojciechowska, W. Krajewski, M. Bolanowski, T. Kręcicki, and T. Zatoński, Diabetes and cancer: A review of current knowledge, Exp. Clin. Endocrinol. Diabetes 124 (2016), pp. 263–275. doi:10.1055/s-0042-100910.
   PubMed Web of Science ®Google Scholar
• U. Galicia-Garcia, A. Benito-Vicente, S. Jebari, A. Larrea-Sebal, H. Siddiqi, K.B. Uribe, H. Ostolaza, and C. Martín, Pathophysiology of type 2 diabetes mellitus, Int. J. Mol. Sci. 21 (2020), pp. 6275. doi:10.3390/ijms21176275.
   PubMed Web of Science ®Google Scholar
• B.O. Roep, S. Thomaidou, R. van Tienhoven, and A. Zaldumbide, Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?), Nat. Rev. Endocrinol. 17 (2021), pp. 150–161. doi:10.1038/s41574-020-00443-4.
   PubMed Web of Science ®Google Scholar
• F. Zhong and Y. Jiang, Endogenous pancreatic β cell regeneration: A potential strategy for the recovery of β cell deficiency in diabetes, Front. Endocrinol. 10 (2019). doi:10.3389/fendo.2019.00101.
   Web of Science ®Google Scholar
• P. Zhou, W. Xie, S. He, Y. Sun, X. Meng, G. Sun, and X. Sun, Ginsenoside Rb1 as an anti-diabetic agent and its underlying mechanism analysis, Cells 8 (2019), pp. 204. doi:10.3390/cells8030204.
   PubMed Web of Science ®Google Scholar
• M. Hatting, C.D.J. Tavares, K. Sharabi, A.K. Rines, and P. Puigserver, Insulin regulation of gluconeogenesis, Ann. N. Y. Acad. Sci. 1411 (2018), pp. 21–35. doi:10.1111/nyas.13435.
   PubMed Web of Science ®Google Scholar
• V. Krishnan, R. Rani, M. Awana, D. Pitale, A. Kulshreshta, S. Sharma, H. Bollinedi, A. Singh, B. Singh, A.K. Singh, and S. Praveen, Role of nutraceutical starch and proanthocyanidins of pigmented rice in regulating hyperglycemia: Enzyme inhibition, enhanced glucose uptake and hepatic glucose homeostasis using in vitro model, Food Chem. 335 (2021), pp. 127505. doi:10.1016/j.foodchem.2020.127505.
   PubMed Web of Science ®Google Scholar
• O. Abid, S. Imran, M. Taha, N.H. Ismail, W. Jamil, S.M. Kashif, K.M. Khan, and J. Yusoff, Synthesis, β-glucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids, Mol. Divers. 25 (2021), pp. 995–1009. doi:10.1007/s11030-020-10084-4.
   PubMed Web of Science ®Google Scholar
• A.E. Von Ah Morano, G.P. Dorneles, A. Peres, and F.S. Lira, The role of glucose homeostasis on immune function in response to exercise: The impact of low or higher energetic conditions, J. Cell. Physiol. 235 (2020), pp. 3169–3188. doi:10.1002/jcp.29228.
   PubMed Web of Science ®Google Scholar
• S. Padhi, A.K. Nayak, and A. Behera, Type II diabetes mellitus: A review on recent drug based therapeutics, Biomed. Pharmacother. 131 (2020), pp. 110708. doi:10.1016/j.biopha.2020.110708.
   PubMed Web of Science ®Google Scholar
• A.K.D. Bin Ahmad Kamar, L. Ju Yin, C. Tze Liang, G. Tjin Fung, and V.R. Avupati, Rhodanine scaffold: A review of antidiabetic potential and structure–activity relationships (SAR), Med. Drug Discov. 15 (2022), pp. 100131. doi:10.1016/j.medidd.2022.100131.
   Google Scholar
• A. Rammohan, B.V. Bhaskar, N. Venkateswarlu, W. Gu, and G.V. Zyryanov, Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents, Bioorg. Chem. 95 (2020), pp. 103527. doi:10.1016/j.bioorg.2019.103527.
   PubMed Web of Science ®Google Scholar
• A.K. Ghosh, W.L. Robinson, J. Gulliver, and H.M. Simpson, Convergent synthesis of (+)-carambolaflavone A, an antidiabetic agent using a bismuth triflate-catalyzed C-aryl glycosylation, Org. Biomol. Chem. 20 (2022), pp. 2822–2830. doi:10.1039/D2OB00038E.
   PubMed Web of Science ®Google Scholar
• P. Kumar, M. Duhan, K. Kadyan, J. Sindhu, S. Kumar, and H. Sharma, Synthesis of novel inhibitors of α-amylase based on the thiazolidine-4-one skeleton containing a pyrazole moiety and their configurational studies, MedChemComm 8 (2017), pp. 1468–1476. doi:10.1039/C7MD00080D.
   PubMed Web of Science ®Google Scholar
• P. Kumar, M. Duhan, J. Sindhu, K. Kadyan, S. Saini, and N. Panihar, Thiazolidine-4-one clubbed pyrazoles hybrids: Potent α-amylase and α-glucosidase inhibitors with NLO properties, J. Heterocycl. Chem. 57 (2020), pp. 1573–1587. doi:10.1002/jhet.3882.
   Web of Science ®Google Scholar
• G.-J. Ye, T. Lan, Z.-X. Huang, X.-N. Cheng, C.-Y. Cai, S.-M. Ding, M.-L. Xie, and B. Wang, Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-glucosidase inhibition and glucose uptake promotion, Eur. J. Med. Chem. 177 (2019), pp. 362–373. doi:10.1016/j.ejmech.2019.05.045.
   PubMed Web of Science ®Google Scholar
• M. Gollapalli, M. Taha, M.T. Javid, N.B. Almandil, F. Rahim, A. Wadood, A. Mosaddik, M. Ibrahim, M.A. Alqahtani, and Y.A. Bamarouf, Synthesis of benzothiazole derivatives as a potent α-glucosidase inhibitor, Bioorg. Chem. 85 (2019), pp. 33–48. doi:10.1016/j.bioorg.2018.12.021.
   PubMed Web of Science ®Google Scholar
• M. Bule, N. Jalalimanesh, Z. Bayrami, M. Baeeri, and M. Abdollahi, The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools, Chem. Biol. Drug Des. 98 (2021), pp. 954–967. doi:10.1111/cbdd.13750.
   PubMed Web of Science ®Google Scholar
• L. Zhao, H.L. Ciallella, L.M. Aleksunes, and H. Zhu, Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling, Drug Discov. Today 25 (2020), pp. 1624–1638. doi:10.1016/j.drudis.2020.07.005.
   PubMed Web of Science ®Google Scholar
• P. Kumar and A. Kumar, Nucleobase sequence based building up of reliable QSAR models with the index of ideality correlation using Monte Carlo method, J. Biomol. Struct. Dyn. 38 (2020), pp. 3296–3306. doi:10.1080/07391102.2019.1656109.
   PubMed Web of Science ®Google Scholar
• S. Ahmadi, S. Lotfi, and P. Kumar, A Monte Carlo method based QSPR model for prediction of reaction rate constants of hydrated electrons with organic contaminants, SAR QSAR Environ. Res. 31 (2020), pp. 935–950. doi:10.1080/1062936X.2020.1842495.
   PubMed Web of Science ®Google Scholar
• M. Nimbhal, K. Bagri, P. Kumar, and A. Kumar, The index of ideality of correlation: A statistical yardstick for better QSAR modeling of glucokinase activators, Struct. Chem. 31 (2019), pp. 831–839. doi:10.1007/s11224-019-01468-w.
   Web of Science ®Google Scholar
• S.C. Manisha, P. Kumar, and A. Kumar, Development of prediction model for fructose-1,6- bisphosphatase inhibitors using the Monte Carlo method, SAR QSAR Environ. Res. 30 (2019), pp. 145–159. doi:10.1080/1062936X.2019.1568299.
   PubMed Web of Science ®Google Scholar
• A. Kumar and P. Kumar, Prediction of power conversion efficiency of phenothiazine-based dye-sensitized solar cells using Monte Carlo method with index of ideality of correlation, SAR QSAR Environ. Res. 32 (2021), pp. 817–834. doi:10.1080/1062936X.2021.1973095.
   PubMed Web of Science ®Google Scholar
• A. Kumar and P. Kumar, Quantitative structure toxicity analysis of ionic liquids toward acetylcholinesterase enzyme using novel QSTR models with index of ideality of correlation and correlation contradiction index, J. Mol. Liq. 318 (2020), pp. 114055. doi:10.1016/j.molliq.2020.114055.
   Web of Science ®Google Scholar
• K. Bagri, A. Kumar, M. Nimbhal, and P. Kumar, Index of ideality of correlation and correlation contradiction index: A confluent perusal on acetylcholinesterase inhibitors, Mol. Simul. 46 (2020), pp. 777–786. doi:10.1080/08927022.2020.1770753.
   Web of Science ®Google Scholar
• A. Kumar and P. Kumar, Identification of good and bad fragments of tricyclic triazinone analogues as potential PKC-θ inhibitors through SMILES–based QSAR and molecular docking, Struct. Chem. 32 (2020), pp. 149–165. doi:10.1007/s11224-020-01629-2.
   Web of Science ®Google Scholar
• A.A. Toropov, R. Carbó-Dorca, and A.P. Toropova, Index of ideality of correlation: New possibilities to validate QSAR: A case study, Struct. Chem. 29 (2018), pp. 33–38. doi:10.1007/s11224-017-0997-9.
   Web of Science ®Google Scholar
• P. Kumar and A. Kumar, CORAL: QSAR models of CB1 cannabinoid receptor inhibitors based on local and global SMILES attributes with the index of ideality of correlation and the correlation contradiction index, Chemom. Intell. Lab. Syst. 200 (2020), pp. 103982. doi:10.1016/j.chemolab.2020.103982.
   Web of Science ®Google Scholar
• P. Kumar and A. Kumar, Correlation intensity index (CII) as a benchmark of predictive potential: Construction of quantitative structure activity relationship models for anti-influenza single-stranded DNA aptamers using Monte Carlo optimization, J. Mol. Struct. 1246 (2021), pp. 131205. doi:10.1016/j.molstruc.2021.131205.
   Web of Science ®Google Scholar
• A. Kumar and P. Kumar, Cytotoxicity of quantum dots: Use of quasiSMILES in development of reliable models with index of ideality of correlation and the consensus modelling, J. Hazard. Mater. 402 (2021), pp. 123777. doi:10.1016/j.jhazmat.2020.123777.
   PubMed Web of Science ®Google Scholar
• K. Roy, P. Ambure, S. Kar, and P.K. Ojha, Is it possible to improve the quality of predictions from an “intelligent” use of multiple QSAR/QSPR/QSTR models? J. Chemom. 32 (2018), pp. e2992. doi:10.1002/cem.2992.
   Web of Science ®Google Scholar
• P. Kumar and A. Kumar, Unswerving modeling of hepatotoxicity of cadmium containing quantum dots using amalgamation of quasiSMILES, index of ideality of correlation, and consensus modeling, Nanotoxicology 15 (2021), pp. 1199–1214. doi:10.1080/17435390.2021.2008039.
   PubMed Web of Science ®Google Scholar
• M. Duhan, J. Sindhu, P. Kumar, M. Devi, R. Singh, R. Kumar, S. Lal, A. Kumar, S. Kumar, and K. Hussain, Quantitative structure activity relationship studies of novel hydrazone derivatives as α-amylase inhibitors with index of ideality of correlation, J. Biomol. Struct. Dyn. (2020), pp. 1–22. doi:10.1080/07391102.2020.1863861.
   Web of Science ®Google Scholar
• M. Duhan, P. Kumar, J. Sindhu, R. Singh, M. Devi, A. Kumar, R. Kumar, and S. Lal, Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids as efficient α-amylase inhibitors: Synthesis, characterization, inhibition, molecular docking, molecular dynamics and Monte Carlo based QSAR studies, Comput. Biol. Med. 138 (2021), pp. 104876. doi:10.1016/j.compbiomed.2021.104876.
   PubMed Web of Science ®Google Scholar
• A.K. Halder, Finding the structural requirements of diverse HIV-1 protease inhibitors using multiple QSAR modelling for lead identification, SAR QSAR Environ. Res. 29 (2018), pp. 911–933. doi:10.1080/1062936X.2018.1529702.
   PubMed Web of Science ®Google Scholar
• W. Liman, M. Oubahmane, I. Hdoufane, I. Bjij, D. Villemin, R. Daoud, D. Cherqaoui, and A. El Allali, Monte Carlo method and GA-MLR-Based QSAR modeling of NS5A inhibitors against the hepatitis C virus, Molecules 27 (2022), pp. 2729. doi:10.3390/molecules27092729.
   PubMed Web of Science ®Google Scholar
• S. Ahmadi, S. Lotfi, S. Afshari, P. Kumar, and E. Ghasemi, CORAL: Monte Carlo based global QSAR modelling of Bruton tyrosine kinase inhibitors using hybrid descriptors, SAR QSAR Environ. Res. 32 (2021), pp. 1013–1031. doi:10.1080/1062936X.2021.2003429.
   PubMed Web of Science ®Google Scholar
• A.A. Toropov and A.P. Toropova, Correlation intensity index: Building up models for mutagenicity of silver nanoparticles, Sci. Total Environ. 737 (2020), pp. 139720. doi:10.1016/j.scitotenv.2020.139720.
   PubMed Web of Science ®Google Scholar
• A.P. Toropova, A.A. Toropov, A. Lombardo, G. Lavado, and E. Benfenati, Paradox of ‘ideal correlations’: Improved model for air half-life of persistent organic pollutants, Environ. Technol. 43 (2022), pp. 2510–2515. doi:10.1080/09593330.2021.1882588.
   PubMed Web of Science ®Google Scholar
• P. De, S. Kar, P. Ambure, and K. Roy, Prediction reliability of QSAR models: An overview of various validation tools, Arch. Toxicol. 96 (2022), pp. 1279–1295. doi:10.1007/s00204-022-03252-y.
   PubMed Web of Science ®Google Scholar
• A.K. Halder, A.S. Moura, and M.N.D.S. Cordeiro, QSAR modelling: A therapeutic patent review 2010-present, Expert Opin. Ther. Pat. 28 (2018), pp. 467–476. doi:10.1080/13543776.2018.1475560.
   PubMed Web of Science ®Google Scholar
• A.A. Toropov and A.P. Toropova, QSAR as a random event: Criteria of predictive potential for a chance model, Struct. Chem. 30 (2019), pp. 1677–1683. doi:10.1007/s11224-019-01361-6.
   Web of Science ®Google Scholar
• T. Huang, G. Sun, L. Zhao, N. Zhang, R. Zhong, and Y. Peng, Quantitative structure-activity relationship (QSAR) studies on the toxic effects of nitroaromatic compounds (NACs): A systematic review, Int. J. Mol. Sci. 22 (2021), pp. 8557. doi:10.3390/ijms22168557.
   PubMed Web of Science ®Google Scholar
• A.A. Toropov and A.P. Toropova, The index of ideality of correlation: A criterion of predictive potential of QSPR/QSAR models? Mutat. Res. Genet. Toxicol. Environ. Mutagen. 819 (2017), pp. 31–37. doi:10.1016/j.mrgentox.2017.05.008.
   PubMed Web of Science ®Google Scholar
• S. Kar, K. Roy, and J. Leszczynski, Applicability domain: A step toward confident predictions and decidability for QSAR modeling, Comput. Toxicol. (2018), pp. 141–169. O. Nicolotti, ed., Springer New York, New York. doi:10.1007/978-1-4939-7899-1_6.
   Google Scholar
• Y. Tian, S. Zhang, H. Yin, and A. Yan, Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods, Chemom. Intell. Lab. Syst. 196 (2020), pp. 103888. doi:10.1016/j.chemolab.2019.103888.
   Web of Science ®Google Scholar
• T. Ghiasi, S. Ahmadi, E. Ahmadi, M.R. Talei Bavil Olyai, and Z. Khodadadi, The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors, SAR QSAR Environ. Res. 32 (2021), pp. 495–520. doi:10.1080/08927022.2020.1770753.
   PubMed Web of Science ®Google Scholar
• P. Kumar and A. Kumar, In silico enhancement of azo dye adsorption affinity for cellulose fibre through mechanistic interpretation under guidance of QSPR models using Monte Carlo method with index of ideality correlation, SAR QSAR Environ. Res. 31 (2020), pp. 697–715. doi:10.1080/1062936X.2020.1806105.
   PubMed Web of Science ®Google Scholar
• O. Trott and A.J. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem. 31 (2010), pp. 455–461. doi:10.1002/jcc.21334.
   PubMed Web of Science ®Google Scholar
• K. Jafari, M.H. Fatemi, A.P. Toropova, and A.A. Toropov, Correlation intensity index (CII) as a criterion of predictive potential: Applying to model thermal conductivity of metal oxide-based ethylene glycol nanofluids, Chem. Phys. Lett. 754 (2020), pp. 137614. doi:10.1016/j.cplett.2020.137614.
   Web of Science ®Google Scholar
• S. Ahmadi, A.P. Toropova, and A.A. Toropov, Correlation intensity index: Mathematical modeling of cytotoxicity of metal oxide nanoparticles, Nanotoxicology 14 (2020), pp. 1118–1126. doi:10.1080/17435390.2020.1808252.
   PubMed Web of Science ®Google Scholar
• A.A. Toropov, N. Sizochenko, A.P. Toropova, D. Leszczynska, and J. Leszczynski, Advancement of predictive modeling of zeta potentials (ζ) in metal oxide nanoparticles with correlation intensity index (CII), J. Mol. Liq. 317 (2020), pp. 113929. doi:10.1016/j.molliq.2020.113929.
   Web of Science ®Google Scholar
• P. Kumar, A. Kumar, and D. Singh, CORAL: Development of a hybrid descriptor based QSTR model to predict the toxicity of dioxins and dioxin-like compounds with correlation intensity index and consensus modelling, Environ. Toxicol. Pharmacol. 93 (2022), pp. 103893. doi:10.1016/j.etap.2022.103893.
   PubMed Web of Science ®Google Scholar
• P. Kumar, A. Kumar, S. Lal, D. Singh, S. Lotfi, and S. Ahmadi, CORAL: Quantitative Structure Retention Relationship (QSRR) of flavors and fragrances compounds studied on the stationary phase methyl silicone OV-101 column in gas chromatography using correlation intensity index and consensus modelling, J. Mol. Struct. 1265 (2022), pp. 133437. doi:10.1016/j.molstruc.2022.133437.
   Web of Science ®Google Scholar
• E.-S.N. Khaldun, M. Al Azzam, and H.Y. Aboul-Enein, ADME studies of TUG-770 (a GPR-40 inhibitor agonist) for the treatment of type 2 diabetes using SwissADME predictor: In silico study, J. Appl. Pharm. Sci. 12 (2022), pp. 159–169. doi:10.7324/JAPS.2022.120418.
   Google Scholar
• Z.Y. Ibrahim, A. Uzairu, G.A. Shallangwa, and S.E. Abechi, Application of QSAR method in the design of enhanced antimalarial derivatives of azetidine-2-carbonitriles, their molecular docking, drug-likeness, and SwissADME properties, Iran. J. Pharm. Res. 20 (2021), pp. 254–270. doi:10.22037/ijpr.2021.114536.14901.
   PubMed Web of Science ®Google Scholar
• Y. Sicak, Design and antiproliferative and antioxidant activities of furan-based thiosemicarbazides and 1,2,4-triazoles: Their structure-activity relationship and SwissADME predictions, Med. Chem. Res. 30 (2021), pp. 1557–1568. doi:10.1007/s00044-021-02756-z.
   Web of Science ®Google Scholar